These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 8098370

  • 1. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T, Nishimura N, Morita T, Sukamoto T.
    J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
    [Abstract] [Full Text] [Related]

  • 2. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K, Yamada H, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [Abstract] [Full Text] [Related]

  • 3. Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery.
    Yanagisawa T, Yamagishi T, Okada Y.
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():565-74. PubMed ID: 8251426
    [Abstract] [Full Text] [Related]

  • 4. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T, Angus JA.
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [Abstract] [Full Text] [Related]

  • 5. Ca2+ influx induced by the agonist U46619 is inhibited by hyperpolarization induced by the K+ channel opener cromakalim in canine coronary artery.
    Yamagishi T, Yanagisawa T, Taira N.
    Jpn J Pharmacol; 1992 Jul; 59(3):291-9. PubMed ID: 1434126
    [Abstract] [Full Text] [Related]

  • 6. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T, Teshigawara T, Taira N.
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T, Masuda Y, Kawamura N, Fujikura N, Tanaka S.
    Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971
    [Abstract] [Full Text] [Related]

  • 8. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate.
    Kuromaru O, Sakai K.
    Clin Exp Pharmacol Physiol; 1996 Jun; 23(6-7):493-7. PubMed ID: 8800572
    [Abstract] [Full Text] [Related]

  • 9. Modulation of intracellular calcium by potassium channel openers in vascular muscle.
    Erne P, Hermsmeyer K.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):706-15. PubMed ID: 1775202
    [Abstract] [Full Text] [Related]

  • 10. KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.
    Glavind-Kristensen M, Matchkov V, Hansen VB, Forman A, Nilsson H, Aalkjaer C.
    Br J Pharmacol; 2004 Dec; 143(7):872-80. PubMed ID: 15504751
    [Abstract] [Full Text] [Related]

  • 11. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE.
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [Abstract] [Full Text] [Related]

  • 12. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
    Ksoll E, Parsons AA, Mackert JR, Schilling L, Wahl M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
    [Abstract] [Full Text] [Related]

  • 13. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA, Stork AP.
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relaxant effect of levcromakalim in isolated human small subcutaneous arteries.
    Hüsken BC, Vroom MB, Timmenga EJ, Pfaffendorf M, Van Zwieten PA.
    Eur J Pharmacol; 1995 Dec 20; 287(3):313-6. PubMed ID: 8991807
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential effects of pinacidil and cromakalim on vascular relaxation and sympathetic neurotransmission.
    Cai B, Hao Q, Greenberg SS, deBoisblanc B, Gillott D, Goharderakhshan R, Summer WR, Hyman A, Lippton H.
    Can J Physiol Pharmacol; 1994 Jul 20; 72(7):801-10. PubMed ID: 7828089
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C, Coldwell MC, Howlett DR, Cooper SM, Hamilton TC.
    Eur J Pharmacol; 1988 Aug 02; 152(3):331-9. PubMed ID: 2851450
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.